SEC Filings

Filing date	Form	Description	View
11/03/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-114114.pdf 0001104659-22-114114.rtf 0001104659-22-114114.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10/21/22	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001877589-22-000006.pdf 0001877589-22-000006.rtf 0001877589-22-000006.xls
10/06/22	CORRESP	CORRESP	View HTML 0001104659-22-106858.pdf 0001104659-22-106858.rtf 0001104659-22-106858.xls
09/29/22	UPLOAD	UPLOAD	View HTML 0000000000-22-010732.pdf 0000000000-22-010732.rtf
09/28/22	SC TO-I	Tender offer schedule and amendment filed by the issuer.	View HTML 0001104659-22-103472.pdf 0001104659-22-103472.rtf 0001104659-22-103472.xls
09/28/22	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001357550-22-000107.pdf 0001357550-22-000107.rtf 0001357550-22-000107.xls
09/20/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-101560.pdf 0001104659-22-101560.rtf 0001104659-22-101560.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
09/20/22	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001387131-22-009895.pdf 0001387131-22-009895.rtf 0001387131-22-009895.xls
09/20/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001387131-22-009897.pdf 0001387131-22-009897.rtf 0001387131-22-009897.xls
09/19/22	SC TO-C	Written public communication relating to an issuer or third party tender offer	View HTML 0001104659-22-100987.pdf 0001104659-22-100987.rtf 0001104659-22-100987.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.